FDA NDC Directory · JSON-LD · Markdown

Neostigmine Methylsulfate

NDC 23155-517 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA208230
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNEOSTIGMINE METHYLSULFATE (.5 mg/mL)
Marketing started20221125
Package count1

External sources

Source: openFDA. Public-domain (CC0).